• Lung hypoplasia and persistent pulmonary hypertension are the principal causes of high mortality and morbidity in infants with congenital diaphragmatic hernia (CDH}. Amineand peptide-producing pulmonary neuroendocrine cells (PNEC), widely distributed throughout the airway mucosa, are thought to play an important role in both pulmonary development and regulation of pulmonary vascular tone. Furthermore, recent studies show increased levels of calcitonin gene-related peptide (CGRP), a pulmonary vasodilator produced by PNEC, during chronic hypoxia. The article reports data on morphometric analysis of CGRP immunoreactire PNEC clusters (neuroepithelial bodies, NEB) in a rat model of CDH. CDH was induced in neonatal Sprague Dawley rats by oral administration of 2,4-dichloro-phenyl-p-nitrophenylether (Nitrofen; Rohm Haas, Philadelphia, PA) to the mother at 10 days of gestation. Sections of lungs from term neonatal rats with and without CDH and controls were immunostained for CGRP {marker of NEB) with specific antibody against rat CGRP. NEB size and number of NEB/ area of lung were assessed using a semiautomatic image analysis system. In lungs of neonatal rats with CDH, the number of NEB per surface area of lung parenchyma was significantly increased compared with the age-matched controis. Although the mean size of NEB was larger in CDH, the differences were not significant. This is the first study of PNEC in CDH. Whether the phenomenon observed in this study results in altered NEB function including imbalance in vasoactive mediators requires further studies, especially in the human being. 
C
ONGENITAL diaphragmatic hernia (CDH) is a serious malformation with a high mortality and morbidity caused by pulmonary hypoplasia and pulmonary hypertension. >3 The mortality rate of 40% to 50% has not changed during the past few years despite changing concepts in treatment, including delayed surgery and extracorporeal membrane oxygenation (ECMO). 4 Factors that may contribute to pulmonary hypertension in general as well as in CDH have been studied intensively. Pulmonary neuroendocrine cells (PNEC), a known source of a variety of biological active compounds, have only been studied recently. These amine-and peptide-producing cells are widely distributed throughout the airway mucosa and are found as solitary cells or as clusters that are called neuroepithelial bodies (NEB). s PNEC are thought to play an important role during lung development s,6 and neonatal adaptation, s,7 particularly in the regulation of pulmonary vascular tone. 8 One of the peptides produced by PNEC is calcitonin generelated peptide (CGRP). In human beings, CGRP immunoreactive cells are found from 22 weeks of gestation 9 mostly within the epithelium of distal conducting airways and in nerves around blood vessels. 1° Both in rats and in humans CGRP is known to show a potent vasodilatory sJ°,n and a bronchoconstricting activity. Recent studies showed increased levels of intracellular CGRP in chronically hypoxic rats 12 and in lungs of children with bronchopulmonary dysplasia. 13 Because PNEC were not previously studied in CDH, we investigated the distribution and frequency of CGRP immunoreactive PNEC in a rat model of CDH and pulmonary hypoplasia. TM The aim of this study was to determine whether these cells and their mediators may play a role in problems associated with CDH in newborns.
MATERIALS AND METHODS
Female Sprague-Dawley rats (Harlan Olac, England) were mated overnight (day 0 of gestation). To induce CDH, a subgroup of pregnant rats received orally 100 mg of 2,4-dichloro-phenyl-pnitrophenylether (Nitrofen; Rohm and Haas, Philadelphia, PA), dissolved in 1 rnL of olive oil, on day 10 of gestation. Nitrofen administration induces a left-sided or bilateral diaphragmatic defect in 70% to 90% of the offspring using this protocol. The offsprings of the rats without Nitrofen administration served as normal controls. Food and water were supplied ad libitum during the whole period of pregnancy. At gestational day 22 (term) the mother was anesthesized by inhalation of ether and a cesarean section was performed. The fetuses were removed and killed before any breathing occurred. The presence of a diaphragmatic defect was assessed and the lungs, with trachea attached, were removed for histological examination. Three study groups were 414 IJSSELSTIJN ET AL included: normal controls (n = 7), rats that developed CDH (n = 9) and rats without CDH (non-CDH) (n = 3) in the Nitrofen group.
The lungs were fixed by immersion in Davidson's solution (40 vol% ethanol 100%, 5 vol% acetic acid 96%, I0 vol% formaldehyde 37%, 45 vol% saline; pH 7.3) and embedded in paraffin. Immunostaining for CGRP was performed with specific rabbit polyclonal antibody against rat CGRP (CA-08-220, Cambridge Research Biochemicals, Wilmington, DE) using a well-established protocol, as, 16 Morphometric analysis including measurements of NEB size, number of NEB per section, surface area of lung sections, a n d frequency of NEB (the number of NEB per mm 2 of lung) were performed using Apple Macintosh National Institutes of Health (NIH) Image 1.49 programme.
All values were expressed as mean _ SEM. Group means were compared using the Student's t test, and significance was accepted at 5% level.
RESULTS
All rats except two in the CDH group had major left-sided or bilateral diaphragmatic defects. Two animals with a small right-sided defect were not included in further analysis. In all groups a positive immunostaining for CGRP was detected. More prominent and numerous NEBs were found in the lungs of CDH rats ( Fig 1A) compared with normal controls (Fig 1B) .
The findings of the morphometric analysis are summarized in Table 1 . The pulmonary area in rats exposed to Nitrofen was significantly smaller compared with that of controls (P < .001), and in CDH it was significantly smaller than in non-CDH rats (P < .01). The number of NEB per mm 2 of lung area in rats with CDH was significantly greater compared with that of both other groups (P < .01 compared with controls, P < .05 compared with non-CDH). Furthermore, the mean size of NEB was greater in CDH rats, but this was not statistically significant.
DISCUSSION
Our findings suggest that in rats with CDH and pulmonary hypoplasia there is a proportionally higher number of NEB immunostained for CGRP. Nitrofenexposed animals without CDH had a smaller lung area compared with normal controls. However, the relative frequency of NEB per mm 2 of lung was comparable to the frequency of NEB seen in controls. This suggests that in CDH there may be an additional factor apart from the pulmonary hypoplasia with a resulting delayed maturation of lung parenchyma.
With respect to the role of PNEC in lung development, different hypotheses are put forward. Cutz et al 6 showed that in the developing human lung the differentiation of PNEC proceeds in a craniocaudal direction with more prominent serotonin-immunoreactive cells during the early stages. In contrast, bombesin-immunoreactive cells reach their maximum number at birth. Spindel et al av found that levels of GRP, the mammalian homologue of bombesin, increase during gestation and remain elevated until several months after birth, whereas GRP mRNAs reach their maximum levels from 16 to 30 weeks of gestation and then decline by 34 weeks of gestation. Wada et al 7 studied the developmental changes in the expression of the CGRP gene in rat lungs. CGRPpositive cells did not appear in lung tissue before the 18th day of gestation and declined within 1 week after birth. These studies suggest involvement of PNEC in normal lung development and a possible role for CGRP in pulmonary adaptation from late intrauterine stages to the early neonatal period. Earlier studies from our group in rats showed that morphologically hypoplastic lungs are less mature near term. 18 It can be assumed that in CDH the immaturity of the lungs is also reflected in the number of NEB. The findings of Wada et al 7 do not support this assumption. Further studies are required to show whether our findings reflect immaturity of the lung in CDH or reflect that a new characteristic of the lung in CDH has now been discovered.
Stahlman et al t9 performed a study of colocalization of peptide hormones in PNEC of human fetuses and newborns. They showed that in normal fetuses the percentage of granules labeled for CGRP was consistently lower compared with abnormal fetuses and children dying from pulmonary disease. This percentage increased with the severity of pathological changes, being highest in hyaline membrane disease and bronchopulmonary dysplasia.
Springall et a112,16 described an increase in intracellular levels of CGRP in PNEC of hypoxic rats. This could have important implications in the vasoconstrictor response to hypoxia. Furthermore, Youngson et al 2° showed that NEB are transducers of the hypoxic stimulus and therefore may function as airway chemoreceptors in the regulation of respiration. In our experiment the neonatal rats were killed immediately after a cesarean section before severe hypoxia after birth could occur. The adaptation from intrauterine to extrauterine life is unlikely to explain our findings for the same reason. A process already existing in utero may result in the higher number of NEB seen in CDH. The immunoreactivity of PNEC in CDH in humans is presently being investigated.
Whether an altered NEB function, including imbalance in vasoactive mediators, is involved in the continuing high mortality and morbidity of CDH is still unclear. Further studies in rats and in humans with other mediators such as serotonin are now being performed in our department.
